Literature DB >> 18159314

Burden of chickenpox on families: A study in Quebec.

P De Wals1, M Blackburn, M Guay, G Bravo, D Blanchette, M Douville-Fradet.   

Abstract

OBJECTIVE: To estimate the nonhospital costs of treating chickenpox and to ascertain the opinion of parents regarding the usefulness of vaccination.
DESIGN: Retrospective postal survey.
SETTING: Province of Quebec. PARTICIPANTS: Random sample of 3333 families with children aged six months to 12 years. OUTCOME MEASURES: For cases of chickenpox that occurred between September 1, 1997 and August 31, 1998, the use of health services, time away from school or work, patient care required, direct and indirect costs for the families and the health care system, and the opinion of parents regarding chickenpox and the vaccine were evaluated.
RESULTS: The response rate was 64.7%, and 18.8% of households reported a history of chickenpox, a total of 693 cases. A physician was consulted in 45.8% of these cases, and medication was used in 91.7%. The frequency of hospitalizations was 0.6%. Time away from work or school caused by the disease was 4.1 days on average, with 46.5% of absences being attributed to the risk of contagion. The total average cost of a case of chickenpox was $225. Direct expenses for households accounted for 11% of the total cost, public sector direct costs 7%, indirect costs related to absence from work 38% and caregiving time 45%. A majority of parents (70%) were in favour of a systematic childhood immunization program.
CONCLUSIONS: Chickenpox without complications is disruptive for families, but the direct costs for families and the public sector are relatively small.

Entities:  

Keywords:  Chickenpox; Cost; Immunization; Vaccine; Varicella

Year:  2001        PMID: 18159314      PMCID: PMC2094791          DOI: 10.1155/2001/361070

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  17 in total

1.  A cost benefit analysis of routine varicella vaccination in Spain.

Authors:  J Díez Domingo; M Ridao; J Latour; A Ballester; A Morant
Journal:  Vaccine       Date:  1999-03-17       Impact factor: 3.641

2.  The relative community burden of otitis media and varicella.

Authors:  B P Yawn; R A Yawn; E Lydick
Journal:  Clin Ther       Date:  1996 Sep-Oct       Impact factor: 3.393

3.  The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

Authors:  P Scuffham; N Devlin; J Eberhart-Phillips; R Wilson-Salt
Journal:  Soc Sci Med       Date:  1999-09       Impact factor: 4.634

4.  Costs and benefits of routine varicella vaccination in German children.

Authors:  P Beutels; R Clara; G Tormans; E Van Doorslaer; P Van Damme
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

5.  Direct and indirect costs of chickenpox in young children.

Authors:  M J Ferson; W L Shen; A Stark
Journal:  J Paediatr Child Health       Date:  1998-02       Impact factor: 1.954

6.  Varicella serology among school age children with a negative or uncertain history of chickenpox.

Authors:  T A Lieu; S B Black; H Takahashi; P Ray; A M Capra; H R Shinefield; N E Adler
Journal:  Pediatr Infect Dis J       Date:  1998-02       Impact factor: 2.129

7.  The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France.

Authors:  L Coudeville; F Paree; T Lebrun; J Sailly
Journal:  Vaccine       Date:  1999-01       Impact factor: 3.641

8.  The cost of childhood chickenpox: parents' perspective.

Authors:  T A Lieu; S B Black; N Rieser; P Ray; E M Lewis; H R Shinefield
Journal:  Pediatr Infect Dis J       Date:  1994-03       Impact factor: 2.129

9.  Cost of varicella in France: a study in day care centers.

Authors:  P Saddier; D Floret; H A Guess; F Dürr; J C Peyrieux; D J Weber; S A Plotkin
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

10.  Cost-effectiveness of a routine varicella vaccination program for US children.

Authors:  T A Lieu; S L Cochi; S B Black; M E Halloran; H R Shinefield; S J Holmes; M Wharton; A E Washington
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

View more
  6 in total

1.  Burden of acute otitis media on Canadian families.

Authors:  Eve Dubé; Philippe De Wals; Vladimir Gilca; Nicole Boulianne; Manale Ouakki; France Lavoie; Richard Bradet
Journal:  Can Fam Physician       Date:  2011-01       Impact factor: 3.275

2.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12

3.  Economic Burden of West Nile Virus Disease, Quebec, Canada, 2012-2013.

Authors:  Najwa Ouhoummane; Eric Tchouaket; Anne-Marie Lowe; Ann Fortin; Dahlia Kairy; Anne Vibien; Jessica Kovitz-Lensch; Terry-Nan Tannenbaum; François Milord
Journal:  Emerg Infect Dis       Date:  2019-10       Impact factor: 6.883

4.  National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning.

Authors:  Walter Ricciardi; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2015-09-14

5.  The societal role of lifelong vaccination.

Authors:  Maarten J Postma; Stuart Carroll; Alexandra Brandão
Journal:  J Mark Access Health Policy       Date:  2015-08-12

6.  The impact of varicella vaccination on paediatric herpes zoster epidemiology: a Canadian population-based retrospective cohort study.

Authors:  Ellen Rafferty; Laura Reifferscheid; Margaret L Russell; Stephanie Booth; Lawrence W Svenson; Shannon E MacDonald
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-06-26       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.